Worth up to 9.75 credits!
Available Credits: ACPE-P/T, AMA, ANCC, APA, ASWB, CDR and Attendance
Start Date: June 11, 2024
Expiration Date: June 11, 2027

Intended audience
These activities are designed to meet the educational needs of case managers, coders, dietitians, dietetic technicians, managed care nurses, nurses, nurse practitioners, pharmacists, pharmacy technicians, PAs, physicians, psychologists, social workers, transplant coordinators and other health care professionals..

Activity Description
These activities consist of recordings from the "Essentials of Oncology and Transplant Management for the Health Care Team" held April 11–12, 2024, in Scottsdale, Ariz.

Throughout these activities, faculty will  address current, critical issues in transplant medicine and oncology that you can apply to the management of patients and/or their benefits. Participants will hear about advances, trends and updates on relevant topics within these fields, as well as current and emerging strategies to improve patient care and outcomes.

Learning Objectives
At the end of these educational activities, participants should be able to:

• Compare the distinct advantages and challenges of paired kidney donation and advance donor programs to traditional transplantation methods.
• Discuss current and emerging diagnostic tools and techniques in monitoring posttransplant graft rejections, including molecular innovations.
• Differentiate the benefits and role of normothermic regional perfusion (NRP) methods and their impact on organ preservation and patient outcomes.
• Recognize the influence of social determinants of health (SDOH) on access to CAR T-cell therapy and patient autonomy, outcomes and experiences and discuss strategies to ensure equitable access.
• Cite the implications of current heart-allocation policies, as well as their effect on ventricular assist device (VAD) utilization and overall transplantation outcomes.
• Identify current and emerging gene therapies targeting hematologic disorders and hematologic cancers.
• Describe advancements in CAR T-cell therapy for the treatment of acute myeloid leukemia.
• Assess advancements in the development of liquid biopsy testing for early cancer detection and describe how these tests can be integrated into clinical settings.
• Examine the broader implications of stem cell transplant advancements in treating hematologic malignancies.
• Discuss the unique emotional challenges faced by patients and health care professionals during the final days of patients with terminal illness and review strategies for health care professionals to foster a supportive and compassionate patient environment through compassionate care that addresses the nuanced needs of these patients and their families.

Agenda
Click on the activity title for more information or to view.

Stem Cell Transplant Therapy: Innovations and Clinical Impact
Joseph Alvarnas, MD
Vice President of Government Affairs
Chief Clinical Advisor, AccessHope™
Professor, Department of Hematology & Hematopoietic Cell Transplantation
City of Hope
1.00 credit

Heart-Allocation Policy and Implications for VADs and Transplant Outcomes
Francisco Arabia, Sr., MD
Professor of Cardiothoracic Surgery
University of Arizona College of Medicine - Tucson;
Physician Executive, Advanced Heart Program
Banner Health
.75 credit

Paired Kidney Donation and Advanced Approaches in Transplantation
Matthew Cooper, MD
Mark B. Adams Chair in Transplant Surgery
Chief, Division of Transplant Surgery
Director, Solid Organ Transplant Service Line
Froedtert Memorial Lutheran Hospital;
Director, Solid Organ Transplantation
Children’s Wisconsin;
Tenured Professor of Surgery
Medical College of Wisconsin
.75 credit

Next-Generation Gene Therapies in Hematology and Oncology
Vanessa Ann Fabrizio, MD, MS
Assistant Professor of Pediatrics
The University of Colorado School of Medicine;
BMT/CT Fellowship Director, Center for Cancer and Blood Disorders
Children’s Hospital Colorado
1.00 credit

Expanding the Donor Pool: The Impact and Advantages of Normothermic Regional Perfusion in Donation after Circulatory Death
Bonnie E. Lonze, MD, PhD
Associate Professor, Department of Surgery
NYU Grossman School of Medicine;
Director of Research
Director, Incompatible Kidney Transplant Program
NYU Langone Transplant Institute
.75 credit

Liquid Biopsies: Continuing to Revolutionize Early Cancer Detection
Philip Mack, PhD
Professor and Associate Director
Center for Thoracic Oncology
Mount Sinai Health System
.75 credit

Advancements in CAR T-Cell Therapy for Acute Myeloid Leukemia: Overcoming Barriers and Optimizing Therapeutic Outcomes
Navneet Majhail, MD, MS, FASTCT
Physician-in-Chief of Blood Cancers
Director, Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial
Sarah Cannon Cancer Institute
1.00 credit

Optimizing Value in Transplant Candidates with End-Stage Liver Disease with Organ Preservation
Amit K. Mathur, MD, MS, FACS
Consultant, Division of Transplant Surgery
Professor of Surgery, Mayo Clinic College of Medicine & Science
Surgical Director, Liver Transplantation, Mayo Clinic in Arizona
Director, Enterprise Transplant Quality and Compliance Workgroup, Mayo Clinic
Associate Medical Director (Transplant), Mayo Clinic Contracting and Payer Relations
Program Evaluation Specialist, National Living Donor Assistance Center
.50 credit

Keynote: Navigating Intestinal Failure and Rehabilitation: Patient Empowerment and Medical Strategy
David F. Mercer, MD, PhD, FRCS (C), FACS
Professor, Department of Surgery, Division of Transplantation
Director of Intestinal Rehabilitation Program
University of Nebraska Medical Center

Marie Neumann, MA
Co-founder, The Gutsy Perspective
Parent of a child with SBS-IF
Researcher
University of Nebraska Medical Center
1.00 credit

Social Determinants in CAR T-Cell Therapy
Javier L. Munoz, MD, MBA
Hematologist & Oncologist
Director, Lymphoma Program
Mayo Clinic in Arizona
.75 credit

Posttransplant Diagnostics: From Traditional Monitoring to Molecular Innovations
Satish Nadig, MD, PhD, FACS
Edward G. Elcock Professor of Surgery
Professor Microbiology/Immunology, & Pediatrics
Chief, Division of Abdominal Transplant Surgery
Director, Comprehensive Transplant Center
Northwestern Medicine
.75 credit

AI Advancements in Transplant Medicine: Enhancing Patient Care and Outcomes
Mark Stegall, MD
Consultant, Division of Transplantation Surgery
Department of Surgery
Consultant, Department of Immunology
Professor of Surgery
Mayo Clinic
.75 credit

Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Participants will receive a certificate upon successful completion of the activity, which includes the following:

• Completing the entire activity
• Completing the Activity Evaluation and Application for Certificate of Credit forms

You must be logged into your account to participate in this activity. Get started by clicking the down arrow and then "Start" under “Activity Video & Materials”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”

Provided By
These activities are provided by Optum Health Education.

Commercial Support
There was no commercial support provided for these activities.

Hardware/Software Requirements
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.